2025 Behavioral Neurology & Neuropsychiatry Reading List

Reading List

Please click below to access the 2025 Behavioral Neurology & Neuropsychiatry reading list.

2025 Behavioral Neurology & Neuropsychiatry Reading List »

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

Upon completion of this UCNS C-cert activity, participants will be able to:
  • Recognize the neuropsychiatric symptoms that pediatric patients may experience after brain tumor resection
  • Identify the needs of patients with neurodevelopmental disorders as they transition from pediatric to adult health care
  • Articulate the appropriate use of testing in Alzheimer’s disease and other forms of dementia, including APOE genotyping and evaluation for treatment-responsive causes of more rapidly progressive dementias
  • Describe the data that supports the conclusion that functional neurological disorders are not feigned symptoms
  • Identify the most appropriate medication choice for neuropsychiatric symptoms in neurodegenerative disorders

Core Competencies

This UCNS C-cert activity covers the following core competencies:
  • Medical Knowledge
  • Patient Care
  • Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry and Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved this activity as part of a comprehensive self-assessment (SA) CME activity, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of continuing certification.

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy

2025 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Behavioral Neurology & Neuropsychiatry Certification Examination Committee Contributors

James R. Bateman, III, MD, MPH, Chair, Wake Forest Baptist Medical Center 
Disclosures: Received honoraria from The North Carolina Area Health Education Centers for CME lectures. Received honoraria from Spier Biomedical Sciences and NovoNordisk for participating in conversations related to Alzheimer's disease diagnostic pathways. Will be receiving honoraria in the coming months for working with a CME company, EfficientCME, for delivery of lecture material about Alzheimer's disease treatment pathways; receive research support (paid to the institution) from the National Institutes of Health, Alzheimer's Association, Dementia Alliance of North Carolina, and the Alzheimer's Drug Discovery Foundation. 

Lindsey Gurin, MD, Vice Chair, NYU Langone
Disclosures: Consultant for Administration of Community Living / Health Services Research Institute - TBI Technical Assistance Research Center (TARC) project; received $1500 honorarium for contribution to written materials and virtual speakers' panel.

Robin A. Hurley, MD, W.G. Hefner VA Medical Center
Disclosures: Receive research grant support from the Veterans Health Administration for our research department. Dr. Hurley’s salary is NOT related to grant money - it is set as a standard salary from the VA for a physician. None of the UCNS work is in conflict with any research grants that her department has; her salary as a physician comes from the Department of Veterans Affairs; her husband's nurse practitioner salary comes from Daymark, the 501C3 non-profit that treats the indigent mental health patients in NC (i.e. NC state govt contract), neither of which have any conflicts with UCNS.

Kyle J. Steinman, MD, MAS, Vice Chair, University of Washington/Seattle Children's Hospital
Disclosures: Receive NIH extramural research funding.

Lealani Mae Acosta, MD, Vanderbilt Medical Center
Disclosures: Receive compensation as Associate editor for the journal Neurology (Humanities section); participate in industry sponsored clinical trials as principal investigator with AbbVie, Sage Therapeutics, and CND Life Sciences. Also study physician on NIH grant-funded studies.

Jonathan H. Woodcock, MD, University of Colorado – Anschutz Medical Campus
Disclosures: Received compensation as expert testimony for clients of multiple law firms and the State of Colorado public defenders. The relationship is consultant - expert witness.

Michael J. Schrift, DO, MA, University of Washington
Disclosures: Nothing to disclose.

Mandana Modirrousta, MD, PhD, St. Boniface Hospital, Winnipeg, MB, Canada
Disclosures: Shareholder of Brain Matters. Brain Matters Inc. own a percentage of royalty for the invention 08003 & 10095.

Jesse M. Adams, MD, Seattle Neuropsychiatric Treatment Center
Disclosures: Nothing to disclose.

Samantha K. Holden, MD, MS, University of Colorado School Medicine
Disclosures: Receive research support from National Institute on Aging

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326